<b><i>Objectives:</i></b> Social media (SM) are evolving and dynamic applications which can be used in health-care settings to enhance professional networking and education; patient communication, care, and education; public health programs; organizational promotion; and research. This review aims to analyze, summarize, and describe the current Saudi experience of SM use for health. <b><i>Methods:</i></b> A MEDLINE/PubMed electronic database search was performed in July 2020 utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. The initial search has yielded a total of 263 articles, of which 25 met our inclusion criteria. <b><i>Results:</i></b> In Saudi Arabia, the literature reports a high interest in using SM for health-related purposes among the public, with a prevalence of >51%. The Saudi population has been found to highly favor the use of WhatsApp and Twitter for gaining and exchanging knowledge. Multiple facilitators and barriers have been identified and further categorized based on the users’ population, such as general public, health-care practitioners, and patients with specific conditions. Overall, the common facilitator and barrier between all users’ population categories were found to be younger age and lack of time, respectively. <b><i>Conclusion:</i></b> SM use for health-care activities is increasing in Saudi Arabia. Thus, it is important for SM-based health education programs to target specific population and patients’ demographics with programs tailored to their particular interests and needs. This is particularly evident in the current achievements and future plans of the Saudi Ministry of Health.
Case series
Patients: Male, 29-year-old • Male, 42-year-old • Male, 26-year-old
Final Diagnosis: Empyema
Symptoms: Abdominal pain • dyspnea
Medication: —
Clinical Procedure: —
Specialty: Surgery
Objective:
Rare coexistence of disease or pathology
Background:
Pyogenic liver abscess is an uncommon entity that is potentially lethal. Pleural empyema and mediastinal collection are 2 rare complications of hepatic abscess that negatively impact the prognosis.
Case Reports:
Herein, we report 3 cases of pyogenic liver abscesses complicated by pleural empyema, each approached differently, along with a succinct review of the literature. Case 1: A 29-year-old man diagnosed with Crohn’s disease presented with Crohn’s disease-associated hepatic abscess complicated by pleural empyema and concurrent mediastinal collection. The patient demonstrated significant improvement after administration of intrapleural fibrinolytic therapy. Case 2: A 42-year-old man with unremarkable past medical history presented with abdominal pain and dyspnea. Upon investigation, he was found to have massive pleural empyema secondary to liver abscess. In contrast to case 1, case 2 required pleural debridement via video-assisted thoracoscopic surgery followed by formal decortication through a posterolateral thoracotomy. Thereafter, a dramatic clinical improvement was observed. Case 3: A 26-year-old man with history of brucellosis 6 months before was transferred to our facility as a case of pleural empyema secondary to transdiaphragmatic extension of liver abscess. Unlike case 1 and 2, this patient was managed by drainage of hepatic and pleural collections under radiological guidance only, without the need for intrapleural fibrinolytic therapy or surgical intervention.
Conclusions:
The current paper sheds light on one of the uncommon complications of hepatic abscess and contributes to this scant literature by summarizing pertinent publications. Adequate drainage remains the cornerstone of any pus collection management despite the complexity of some encountered cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.